Current recommendations for the pharmacological management of BPH include alpha-blockers, 5-ARIs, and phosphodiesterase-5 inhibitors, either alone or in combination.1
Adverse sexual side effects may arise from the drug class as a whole or specific medications within these classes.1,2
Discussing the risks and side effects of BPH pharmacologic therapy is essential to help patients make informed decisions that align with their personal health goals.2
Alpha-blockers are the first-line medical option in the management of BPH.1,2
Among, alpha-blockers, alfuzosin stands out with good efficacy along with fewer sexual side effects than other alpha-blockers in sexually active males.1,2
Alfoo-Improved Pharmacokinetics
ALFOO, containing Alfuzosin molecule, is Anti-BPH which helps in treatment of LUTS due to BPH in Young Sexually Active Male in 40-60 year old age group